CORRESP Filing
Cellectar Biosciences, Inc.
Date: June 30, 2025 · CIK: 0001279704 · Accession: 0001104659-25-063941
AI Filing Summary & Sentiment
File numbers found in text: 333-288333
Show Raw Text
CORRESP
1
filename1.htm
Ladenburg Thalmann & Co. Inc.
640 Fifth Avenue, 4 th Floor
New York, New York 10019
June 30, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, DC 20549
Re:
Cellectar Biosciences, Inc.
Registration Statement on Form S-1 (Registration No.
333-288333)
Concurrence in Acceleration Request
Ladies and Gentlemen:
Ladenburg Thalmann & Co.
Inc. (" Ladenburg "), as representative of the underwriters for the referenced offering, hereby concurs in the request
by Cellectar Biosciences, Inc. that the effective date of the above-referenced registration statement be accelerated to 9:00 a.m. (Eastern
Time), or as soon as practicable thereafter, on July 1, 2025, pursuant to Rule 461 under the Securities Act. Ladenburg affirms that it
is aware of its obligations under the Securities Act in connection with this offering.
Very truly yours,
LADENBURG THALMANN & CO. INC.
By:
/s/ Nicholas Stergis
Name: Nicholas Stergis
Title: Managing Director